Massimo Eli has a degree in “Pharmaceutical Chemistry and Technology” and postgraduated diplomas in “Toxicology” and in “Industrial Pharmacy”.
He is actually employed at Merck/MSD as Clinical Supply Chain Regional Lead for Europe.
He started in 1982 in R&D of “Farmitalia Carlo Erba” in Pharmacokinetics but suddenly (1984) moved to the Solid Dosage Forms Development and Manufacturing till 1994; then he was in charged of Technology Transfer in the merged “Pharmacia and Upjohn” company, where he joined the Clinical Supply area in 1996 when the company became “Pharmacia”. He has been leading the unique non US based packaging site of the company till 2004 when the site was sold by Pfizer to a private owner and he continued in his role till middle 2006, then a short period as QC director before moving to Schering Plough beginning 2007 to cover the actual position, kept after the acquisition from Merck.
He is a licenced QP and has a solid background in Formulation Development, Tech Transfer and Informatic Systems for handling the Supply Chain of Investigational Products.